elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q42371566-231454AF-33C9-4F2F-9B70-5A5518748BB5
Q42371566-231454AF-33C9-4F2F-9B70-5A5518748BB5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42371566-231454AF-33C9-4F2F-9B70-5A5518748BB5
VRK1 promotes cisplatin resistance by up-regulating c-MYC via c-Jun activation and serves as a therapeutic target in esophageal squamous cell carcinoma.
P2860
Q42371566-231454AF-33C9-4F2F-9B70-5A5518748BB5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42371566-231454AF-33C9-4F2F-9B70-5A5518748BB5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8cccb9b4b676043a7817a5eb4262b8a91d2c4e88
P2860
MiR-367 regulates cell proliferation and metastasis by targeting metastasis-associated protein 3 (MTA3) in clear-cell renal cell carcinoma.